Hofseth BioCare ASA (HOFBF PINK) stock market data APIs
$0.1535
0(0%)
as of May 9, 2025
Try our APIs with
free plan!
Hofseth BioCare ASA Financial Data Overview
Hofseth BioCare ASA engages in the production of health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for weight management, and metabolism; CalGo, a calcium collagen complex for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was founded in 2000 and is headquartered in Ålesund, Norway.
Prev. Close
0.1535
Open
0.1535
High
0.1535
Low
0.1535
52 wk Range
0.095-0.2034
Market Cap
78 060 K
Shares Outstanding
395 M
Revenue
266 M
EPS
-0.0092
Beta
0.575
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Hofseth BioCare ASA data using free add-ons & libraries
Get Hofseth BioCare ASA Fundamental Data
Hofseth BioCare ASA Fundamental data includes:
- Net Revenue: 266 M
- EBITDA: -90 708 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-12-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Hofseth BioCare ASA News
New
Hofseth Biocare ASA: ADVANCING THE TREATMENT OF PROSTATE CANCER WITH PUBLICATION OF FTH1 RESEARCH ABSTRACT AHEAD OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) MEETING
Hofseth Biocare ASA HBC is pleased to announce the online publication of its abstract titled “Antiproliferative activity of marine-derived oligopeptides combined with androgen receptor inhibition i...
Hofseth Biocare ASA: SPIN-OFF OF PROSTATE CANCER CO-TREATMENT PROJECT
Hofseth Biocare ASA Hofseth Biocare ASA ("HBC" or the "Company") today announces the decision to transfer its prostate cancer co-treatment project (the "Project") to a new US entity to be called HBC ...
Hofseth BioCare ASA: FIRST QUARTER 2023 FINANCIAL REPORT
Hofseth Biocare ASA The first quarter of 2023 shows a very good development for HBC. Revenues came in at NOK 44m vs NOK 30m last year, a growth of 48 % YoY and 32 % QoQ. The underlying growth we are ...
Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING
Hofseth Biocare ASA Hofseth BioCare ASA held its Annual General Meeting on 28 April 2023. 253,351,609 shares, amounting to 64.13 per cent of the share capital, were represent in the meeting or by pro...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
